Kenvue Inc. (KVUE)
Consumer Defensive
- Fundamental
- 3
- Sentiment
- 3
- Technical
- 4
Buy-stop only above 19.19 to confirm a breakout through the February/March 19.18 ceiling; use GTC, initial stop 18.80, first target 19.97, second target 20.56, and expected R/R is 2.00. If 19.19 does not trigger, stand aside.
Company overview
Kenvue Inc. is a global leader in the consumer health sector, operating across Self Care, Skin Health and Beauty, and Essential Health divisions. The company offers products for conditions like coughs and allergies, skin and hair care solutions, and essential health items under brands such as Tylenol, Neutrogena, and Listerine. Established in 2022, it is headquartered in Skillman, New Jersey, and is a subsidiary of Johnson & Johnson.
Fundamental
fairKenvue shows strong margins and manageable leverage, but weak growth and merger uncertainties weigh on its fundamentals.
KVUE shows defensive, cash-generative fundamentals: TTM gross margin 58.37%, EBITDA margin 20.73%, net margin 10.61% with ROE 15.18% and ROIC 9.76%. Leverage looks manageable (net debt/EBITDA 2.39x, interest coverage 7.64x), though liquidity is tight with a ~0.98 current ratio. Growth has been weak—5-year revenue CAGR ~0.12% and EPS CAGR −8.53%—even as the most recent quarter showed improved profitability. SEC filings highlight a pending Kimberly-Clark merger (stockholder-approved), restructuring actions, and product-liability litigation, which may dominate the near-term narrative.
Sentiment
fairSentiment is neutral, with the Kimberly-Clark acquisition as a key narrative driver.
Media/search coverage continues to focus on the announced but unresolved Kimberly-Clark acquisition of Kenvue (ongoing_process; confidence=announced), which is the main short-term swing factor. Last ~14d sentiment is neutral-to-slightly positive and only modestly firmer than the 30–90d baseline; legal screens show no regulator-confirmed investigations (Red-Flag Screen clean).
Technical
goodThe stock is in a bullish trend, with a potential breakout above 19.18 as a cleaner trigger.
KVUE is technically constructive: the latest daily print around 18.78 and the live quote near 18.77 sit above SMA20/50/200 (17.81/17.56/17.25), EMA9/21 (18.21/17.93), and the day VWAP (~18.70). MACD is positive and above its signal (0.26 vs 0.18), RSI14 is 65.44, and ADX14 is 60.92, confirming strong bullish trend strength. The caution flag is short-term stretch—Williams %R at -3.44 and nearby February/March resistance around 19.00-19.18 argue for a confirmation trigger instead of chasing at market.
You’re looking at 2026-06-24 — about 2 trading days ago.
Subscribers saw this then, and see today’s score, verdict and trade plan now.
More Consumer Defensive
Not financial advice. For informational and educational purposes only.